Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: NASDAQ CM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Catalyst Pharmaceutical Partners Inc

+ Add to Watchlist

CPRX:US

4.1900 USD 0.2800 7.16%

As of 20:10:00 ET on 03/27/2015.

Company Profile for Catalyst Pharmaceutical Partners Inc (CPRX)

Catalyst Pharmaceutical Partners, Inc. is a pharmaceutical company focused on the development and commercialization of prescription drugs for the treatment of addiction. The Company develops drugs for addictions such as methamphetamine, nicotine, prescription pain medications, alcohol, and marijuana, as well as treatments for related addictive disorders, such as obesity and gambling.

Contact Information

Catalyst Pharmaceutical Partners Inc

355 Alhambra Circle
Suite 1370
Coral Gables, FL 33134
United States
Phone: 1-305-529-2522
Fax: 1-305-668-2834

Key Executives for Catalyst Pharmaceutical Partners Inc (CPRX)

Patrick J McEnanyChairman/President/CEO/Co-FounderSteven R MillerChief Operating Officer
Charles W GorodetzkyChief Medical OfficerDavid D MuthExec VP/Chief Commercial Officer
Alicia GrandeVP/CFO/TreasurerBernardino MosqueraVP:Clinical Operations
M Douglas WinshipVP:Regulatory Operations

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil